A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

CompletedOBSERVATIONAL
Enrollment

1,674

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Refractive ErrorGlaucomaCataractsClear Lens Exchange
Interventions
DEVICE

Intervention

No study treatments will be administered during this retrospective study. However, data will be collected from medical records of patients who have been treated with subject devices of this study.

Trial Locations (13)

10559

Augentagesklinik Spreebogen Berlin GbR, Berlin

14012

Hospital La Arruzafa, Córdoba

28008

Clinica Oftalvist, Madrid

28040

Hospital Clinico San Carlos, Madrid

36301

Trinity Research Group, LLC, Dothan

47011

Instituto Universitario de Oftalmobiologia Aplicada, Valladolid

48683

Augenaerzte Gerl & Kollegen MVZ Ahaus GmbH, Ahaus

55420

Chu Vision Institute, Bloomington

78503

Valley Retina Institute, McAllen

93309

Empire Eye and Laser Center, Bakersfield

09405

Augenzentrum Erzgebirge, Zschopau

03015

Clinica Vistahermosa, Alicante

08025

Hosp. De La Santa Creu I Sant Pau, Barcelona

All Listed Sponsors
lead

Johnson & Johnson Surgical Vision, Inc.

INDUSTRY